台股 » 個股 » 慧智 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

慧智

(6615)
  • 股價
    48.90
  • 漲跌
    ▼0.60
  • 漲幅
    -1.21%
  • 成交量
    202
  • 產業
    上櫃 生技醫療類股
  • 41人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
慧智 (6615)籌碼相關-大昌-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

大昌-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0200.00249.5049.50-274-2.70%
2024/04/2500.00142.8048.40-159-1.67%
2024/04/24343.75843.6944.00-554-9.21%
2024/04/23848.2000.0048.2084916.27%
2023/08/0100.00446.8046.85-473-5.46%
2023/06/19440.3000.0040.304586.82%
2023/05/1000.00148.8550.00-130-3.27%
2021/12/0200.00145.8545.85-17-12.63%
2021/11/0800.00145.3045.30-18-11.47%
2021/06/1100.00151.0051.80-143-2.32%
2021/05/12147.0000.0047.101442.24%
2021/05/10149.5000.0049.501442.27%
2021/05/03152.6000.0052.001422.37%
2021/04/1300.00156.0058.00-132-3.10%
2021/04/12154.10153.1054.100240.00%
2021/03/02151.0000.0050.301137.27%
2020/01/0900.00164.2064.30-165-1.53%
2020/01/08163.8000.0063.501661.52%
2019/10/08184.1000.0084.501801.25%
2018/09/2500.00199.80100.00-1161-0.62%
2018/09/111107.5000.00100.0011660.60%
2018/08/3100.001124.50124.50-1162-0.61%
2018/08/301123.0000.00126.0011620.62%
2018/08/2300.001125.00125.00-1174-0.57%
2018/08/221122.0000.00124.0011770.56%
2018/08/2100.001125.00127.50-1177-0.56%
2018/08/171122.0000.00121.0011760.57%
2018/08/1600.002121.25126.00-2177-1.13%
2018/08/151124.0000.00122.5011760.57%
2018/08/081134.0000.00134.0012070.48%
2018/08/0200.002124.75125.50-2221-0.90%
2018/08/012127.0000.00127.0022280.88%
2018/07/3100.006127.75132.00-6236-2.53%
2018/07/1900.002126.50126.00-2303-0.66%
2018/07/173128.3300.00128.0033150.95%
2018/07/133122.6700.00124.0033170.94%
2018/07/122125.0000.00124.0023230.62%
2018/04/1300.0020105.95105.00-20310-6.45%
2018/04/1220113.8800.00116.00203026.62%
2018/01/3000.00189.2086.50-1130-0.77%
2018/01/29192.00288.7589.30-1126-0.79%
2018/01/26288.5000.0088.2021231.62%
2018/01/2500.00188.2087.00-1122-0.82%
2018/01/22193.0000.0090.1011050.94%
〈熱門股〉次世代基因定序明年納健保 創源、慧智帶量上攻Anue鉅亨-2023/08/05
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
慧智 相關文章
慧智 相關影音